| Clinical Trial ID NCT00438529

Clinical Trial ID NCT00438529

Rank	Title	Journal	Year	PubWeight™‹?›
1	Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031.	J Clin Oncol	2011	2.71